EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 197 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $15 | -28.6% | 2,000 | 0.0% | 0.00% | – |
Q1 2023 | $21 | -12.5% | 2,000 | 0.0% | 0.00% | – |
Q4 2022 | $24 | -99.9% | 2,000 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $42,000 | -42.5% | 2,000 | -14.9% | 0.00% | 0.0% |
Q2 2022 | $73,000 | -24.0% | 2,350 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $96,000 | – | 2,350 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |